ATE108188T1 - Laminin bindende peptidfragmente. - Google Patents
Laminin bindende peptidfragmente.Info
- Publication number
- ATE108188T1 ATE108188T1 AT87907048T AT87907048T ATE108188T1 AT E108188 T1 ATE108188 T1 AT E108188T1 AT 87907048 T AT87907048 T AT 87907048T AT 87907048 T AT87907048 T AT 87907048T AT E108188 T1 ATE108188 T1 AT E108188T1
- Authority
- AT
- Austria
- Prior art keywords
- binding peptide
- peptide fragments
- laminin binding
- laminin
- probe
- Prior art date
Links
- 108010033276 Peptide Fragments Proteins 0.000 title 1
- 102000007079 Peptide Fragments Human genes 0.000 title 1
- 239000000523 sample Substances 0.000 abstract 2
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 108010001857 Cell Surface Receptors Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 102000006240 membrane receptors Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/911,863 US4861710A (en) | 1986-09-26 | 1986-09-26 | Recombinant DNA clone encoding laminin receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE108188T1 true ATE108188T1 (de) | 1994-07-15 |
Family
ID=25431000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87907048T ATE108188T1 (de) | 1986-09-26 | 1987-09-23 | Laminin bindende peptidfragmente. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4861710A (de) |
| EP (1) | EP0324788B1 (de) |
| JP (3) | JP2533595B2 (de) |
| AT (1) | ATE108188T1 (de) |
| CA (1) | CA1305678C (de) |
| DE (1) | DE3750180T2 (de) |
| WO (1) | WO1988002407A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990002180A1 (en) * | 1988-08-31 | 1990-03-08 | Dana-Farber Cancer Institute | A FULL LENGTH cDNA ENCODING A HUMAN LAMININ BINDING PROTEIN |
| US5175251A (en) * | 1989-05-04 | 1992-12-29 | Sri International | Antimetastatic peptides with laminin activity |
| CA2040099A1 (en) * | 1990-05-01 | 1991-11-02 | Mariano Barbacid | Tyrosine kinase negative trkb |
| WO2000077201A1 (en) * | 1999-06-15 | 2000-12-21 | Astrazeneca Ab | Livin; inhibitor-of-apoptosis protein-3 (iap-3) |
| WO2002020598A1 (en) * | 2000-07-28 | 2002-03-14 | Michael Andrew Mcguckin | Mucin |
| US20030118585A1 (en) * | 2001-10-17 | 2003-06-26 | Agy Therapeutics | Use of protein biomolecular targets in the treatment and visualization of brain tumors |
| CA2502479A1 (en) * | 2004-12-01 | 2006-06-01 | Procyon Biopharma Inc. | Laminin receptor binding molecule |
| EP2330122A1 (de) | 2009-12-02 | 2011-06-08 | Asklepios Kliniken Hamburg Gmbh | OFA/iLRP-abgeleitetes modifiziertes Peptid |
| GB201700529D0 (en) * | 2017-01-12 | 2017-03-01 | Rogers April | Laminin receptor peptide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4628027A (en) * | 1982-05-19 | 1986-12-09 | Molecular Engineering Associates, Ltd. | Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |
| US4589881A (en) * | 1982-08-04 | 1986-05-20 | La Jolla Cancer Research Foundation | Polypeptide |
| US4699877A (en) * | 1982-11-04 | 1987-10-13 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
| US4565789A (en) * | 1983-04-04 | 1986-01-21 | The United States Of America As Represented By The Department Of Health And Human Services | Cell matrix receptor system and use in cancer diagnosis and management |
-
1986
- 1986-09-26 US US06/911,863 patent/US4861710A/en not_active Expired - Lifetime
-
1987
- 1987-09-23 WO PCT/US1987/002411 patent/WO1988002407A1/en active IP Right Grant
- 1987-09-23 AT AT87907048T patent/ATE108188T1/de active
- 1987-09-23 EP EP87907048A patent/EP0324788B1/de not_active Expired - Lifetime
- 1987-09-23 DE DE3750180T patent/DE3750180T2/de not_active Expired - Fee Related
- 1987-09-23 JP JP62506395A patent/JP2533595B2/ja not_active Expired - Lifetime
- 1987-09-28 CA CA000548000A patent/CA1305678C/en not_active Expired - Lifetime
-
1993
- 1993-04-20 JP JP5116331A patent/JPH06107691A/ja active Pending
-
1995
- 1995-09-01 JP JP7248671A patent/JP2825780B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1305678C (en) | 1992-07-28 |
| JP2533595B2 (ja) | 1996-09-11 |
| JPH0880200A (ja) | 1996-03-26 |
| EP0324788A1 (de) | 1989-07-26 |
| WO1988002407A1 (en) | 1988-04-07 |
| DE3750180D1 (de) | 1994-08-11 |
| EP0324788A4 (de) | 1990-03-28 |
| EP0324788B1 (de) | 1994-07-06 |
| US4861710A (en) | 1989-08-29 |
| JPH02500637A (ja) | 1990-03-08 |
| JPH06107691A (ja) | 1994-04-19 |
| DE3750180T2 (de) | 1994-11-03 |
| JP2825780B2 (ja) | 1998-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
| BR0112542A (pt) | Composições e métodos papa a terapia e a diagnose de câncer ovariano | |
| DK161015C (da) | Blanding til anvendelse ved ekstern paavisning og lokalisering af en blodprop | |
| AR006250A1 (es) | Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico | |
| TW200728465A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| BR0008161A (pt) | Uso de uma composição terapêutica para tratamento de uma célula tumoral, composição terapêutica, e kit para tratamento de uma célula tumoral | |
| ATE438719T1 (de) | Spezifischer marker für prostatakrebs | |
| DE69737788D1 (de) | Reagenzien und methoden zum nachweis von erkrankungen der brust | |
| TR200001646T2 (tr) | Bir salgılanmış meme kanseri proteini olan mamaglobin. | |
| ATE108188T1 (de) | Laminin bindende peptidfragmente. | |
| WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
| DE68921979T2 (de) | Antikörper für die antilymphozyten-antikörpertherapie. | |
| DE69735020D1 (de) | Verfahren zur Diagnose von Prostatakrebs | |
| DE69021742T2 (de) | Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck. | |
| ES522754A0 (es) | Procedimiento de obtener alcaloides del tipo de la berberina y similares. | |
| MXPA03005436A (es) | Polinucleotidos novedosos que codifican fosfastasas humanas. | |
| ES2068388T3 (es) | Moleculas de receptor de hormona de la glucoproteina. | |
| MXPA02011563A (es) | Composicionesy metodos para la terapia y diagnostico de cancer de seno. | |
| HUP9800744A2 (hu) | Fas-antigén elleni antitestek | |
| DK0495910T3 (da) | Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer | |
| DE69830596D1 (de) | Ein tumorsuppressor namens ts10q23.3 | |
| WO1998045442A3 (en) | Secreted f-spondin homologs | |
| EP0928340A4 (de) | Invasionsinduzierende wirkstoffe und invasionsinhibitoren zur verwendung in der wundheilung und krebsbehandlung | |
| ATE435284T1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| IL155687A0 (en) | Polynucleotides encoding hlrrsi1 polypeptides |